Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria

Polish Journal of Microbiology

Volumn 61, Issue 1, 2012, Pages 23-32

  Madania, Amar ^a   Habous, Maya ^b   Zarzour, Hana ^a   Ghoury, Ifad ^a   Hebbo, Barea ^b  

^a DEPARTMENT OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Syrian Arab Republic)

^b Ministry of Health   (Syrian Arab Republic)

Author keywords

inhA; katG; M. Tuberculosis; MDR; MGB probes; Mutations; rpoB

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POINT MUTATION; REAL TIME POLYMERASE CHAIN REACTION; SYRIAN ARAB REPUBLIC;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84860473252     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: 10.33073/pjm-2012-003     Document Type: Article

References (33)

1. Baker L.V., T.J. Brown, O. Maxwell, A.L. Gibson, Z. Fang, M.D. Yates and F.A. Drobniewski. 2005. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC-46A polymorphism. Antimicrob. Agents Chemother. 49: 41455-1464.
2. Bakonyte D., A. Baranauskaite, J. Cicenaite, A. Sosnovskaja and P. Stakenas. 2003. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob. Agents Chemother. 47: 2009-2011.
3. Bobadilla-del-Valle M., A. Ponce-de-Leon, C. Arenas-Huertero, G. Vargas-Alarcon, M. Kato-Maeda, P.M. Small, P. Couary, G.M. Ruiz-Palacios and J. Sifuentes-Osornio. 2001. rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism. Emer. Infect. Dis. 7: 1010-1013.
4. Cavusoglu C., S. Hilmioglu, S. Guneri and A. Bilgic. 2002. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J. Clin. Microbiol. 40: 4435-4438.
5. Dye C. 2006. Global epidemiology of tuberculosis. Lancet 367: 938-940.
6. Ederth J., R. Mooney, L. Isaksson and R. Landick. 2006. Functional interplay between the Jaw Domain of bacterial RNA polymerase and allele-specific residues in the product RNA-binding pocket. J. Mol. Biol. 356: 1163-1179.
7. Fressatti Cardoso R., R. Cooksey, G. Morlock, P. Barco, L. Cecon, F. Forestiero, C.Q.F. Leite, D.N. Sato, M. de Lourdes Shikama, E.M. Mamizuka and others. 2004. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob. Agents Chemother. 48: 3373-3381.
8. Gagneux S. 2009. Fitness cost of drug resistance in Mycobacterium tuberculosis. Clin. Microbiol. Infect. 15:66-68.
9. García de Viedma D. 2003. Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches. Clin. Microbiol. Infect. 9: 349-359.
10. Hazbón M.H., M. Brimacombe, M. Bobadilla del Valle, M. Cavatore, M. Inírida Guerrero, M. Varma-Basil, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia and others. 2006. Population genetics study of isoniazid resistance mutations and evolution of multidrug resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50: 2640-2649.
11. Heep M., B. Brandstatter, U. Rieger, N. Lehn, E. Richter, S. Rusch-Gerdes and S. Niemann. 2001. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 39: 107-110.
12. Herrera L., S. Jimenez, A. Valcerde, M.A. Garcia-Aranda and J.A. Saez-Nieto. 2003. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int. J. Antimicrob. Agents. 21: 403-408.
13. Jiao W., I. Mokrousov, G. Sun, M. Li, J. Liu, O. Narvskaya and A. Shen. 2007. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin. Med. J. 120: 814-819.
14. Kutyavin I.V., I.A. Afonina, A. Mills, V.V. Gorn, E.A. Lukhtanov, E.S. Belousov, M.J. Singer, D.K. Walburger, S.G. Lokhov, A.A. Gall and others. 2000. 3'-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res. 28: 655-661.
15. Mani C., N. Selvakumar, S. Narayanan and P.R. Narayanan. 2001. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J. Clin. Microbiol. 39: 2987-2990.
16. McCammon M., J. Gillette, P. Thomas, V. Ramaswamy, A. Graviss, N. Kreiswirth, J. Vijg and N. Quitugua. 2005. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis. Antimicrob. Agents Chemother. 49: 2200- 2209.
17. Narvaiz de Kantor I., S.J. Kim, T. Frieden, A. Laszlo, F. Luelmo, P.Y. Norval, H. Rieder, P. Valenzuela and K. Weyer. 1998. LABORATORY SERVICES IN TUBERCULOSIS CONTROL, For the Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
18. Ohno H., H. Koga, S. Kohno, T. Tashiro, and K. Hara. 1996. Relationship between rifampin MICs and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40: 1053-1056.
19. Pozzi G., M. Meloni, E. Iona, G. Orro, O.F. Thorensen, M.L. Ricci, M.R. Oggioni, L. Fattorini and G. Orefici. 1999. rpoB mutations in multidrug resistant strains of Mycobacterium tuberculosis isolated in Italy. J. Clin. Microbiol. 37:1197-1199.
20. Ramaswamy S.V. and J.M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung. Dis. 79:3-29.
21. Ramaswamy S.V., R. Reich, S.J. Dou, L. Jasperse, X. Pan, A. Wanger, T. Quitugua and E.A. Graviss. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47: 1241-1250.
22. Rouse, D. A., J. A. DeVito, Z. Li, H. Byer, and S. L. Morris. 1996. Site directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol. Microbiol. 22: 583-592.
23. Silva M.S., S.G. Senna, M.O. Ribeiro, A.R. Valim, M.A. Telles, A. Kritski, G.P. Morlock, R.C. Cooksey, A. Zaha and M.L. Rossetti. 2003. Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 41: 4471-4474.
24. Slayden R.A. and C.E. Barry 3rd. 2000. The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis . Microbes Infect. 2: 659-669.
25. Telenti A., N. Honore, C. Bernasconi, J. March, A. Ortega, B. Heym, H.E. Takiff and S.T. Cole. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35: 719-723.
26. van Soolingen D., P.E. de Haas, H.R. van Doorn, E. Kuijper, H. Rinder and M.W. Borgdorff. 2000. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J. Infect. Dis. 182: 1788-1790.
27. Wada T., S. Maeda, A. Tamaru, S. Imai, A. Hase and K. Kobayashi. 2004. Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J. Clin. Microbiol. 42: 5277-5285.
28. Wei C.J., B. Lei, J.M. Musser and S.C. Tu. 2003. Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production. Antimicrob. Agents Chemother. 47: 670-675.
29. World Health Organization. 2005. Global tuberculosis control: surveillance, planning, financing. WHO report 2005. WHO/HTM/TB/2005.349. Geneva.
30. World Health Organization. 2010. Multidrug and extensively drug resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland.
31. Yuen L.K.W., D. Leslie and P.J. Coloe. 1999. Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia. J. Clin. Microbiol. 37: 3844-3850.
32. Zhang Y. and A. Telenti. 2000. Genetics of drug resistance in Mycobacterium tuberculosis, p. 235-254. In Hatfull F.F and Jacobs W.R Jr. (ed.), Molecular genetics of mycobacteria. ASM Press, Washington, D.C.
33. Zhang M., J. Yue, Y.P. Yang, H.M. Zhang, J.Q. Lei, R.L. Jin, X.L. Zhang and H.H. Wang. 2005. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 43: 5477-5482.